anti human cd3 Search Results


anti cd3  (Bio X Cell)
95
Bio X Cell anti cd3
Anti Cd3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd3/product/Bio X Cell
Average 95 stars, based on 1 article reviews
anti cd3 - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier
anti cd3  (Cytek Biosciences)
90
Cytek Biosciences anti cd3
Anti Cd3, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd3/product/Cytek Biosciences
Average 90 stars, based on 1 article reviews
anti cd3 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
anti human cd3  (Bio-Rad)
96
Bio-Rad anti human cd3
Anti Human Cd3, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human cd3/product/Bio-Rad
Average 96 stars, based on 1 article reviews
anti human cd3 - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
anti cd3  (Biogems International)
93
Biogems International anti cd3
Anti Cd3, supplied by Biogems International, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd3/product/Biogems International
Average 93 stars, based on 1 article reviews
anti cd3 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
anti cd3  (Diaclone)
93
Diaclone anti cd3
Anti Cd3, supplied by Diaclone, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd3/product/Diaclone
Average 93 stars, based on 1 article reviews
anti cd3 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
e ab f1001e  (Elabscience Biotechnology)
93
Elabscience Biotechnology e ab f1001e
The information of antibodies used for western blot, immunohistochemistry, and flow cytometry
E Ab F1001e, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/e ab f1001e/product/Elabscience Biotechnology
Average 93 stars, based on 1 article reviews
e ab f1001e - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
invivomab anti human cd3  (Bio X Cell)
94
Bio X Cell invivomab anti human cd3
a. Dose–response curves showing pSMAD2/3 levels in human CD4- or CD8α-transduced HEK293 cells measured using a pSMAD–induced SEAP assay. b. Dose-dependent curves showing numbers of in vitro –cultured CD4 or CD8 T cells treated with the indicated proteins on day 5. c. Schematic of the experimental design for human spleen organoid culture, LAIV stimulation, and protein treatments. d. Representative flow cytometry plots showing percentages of CD38 Ki-67 cells in CD4 or CD8 T cells from the indicated treatment groups. e. Quantification of CD38 Ki-67 cell percentages in CD4 or CD8 T cells from the indicated treatment groups. f. Quantification of CD38 Ki-67 CD4 or CD8 T cell percentages among total <t>CD3</t> <t>T</t> cells from the indicated treatment groups. g. Dose–response curves showing pSMAD2/3 levels in human CD19-transduced HEK293 cells measured using a pSMAD-induced SEAP assay. h. Representative flow cytometry plots showing CD38 high PB percentages in B cells from the indicated treatment groups. i. Quantification of CD38 high PB percentages among total leukocytes from the indicated treatment groups. j. Quantification of CD38 expression levels in CD38 low non-PB from the indicated treatment groups. k. Quantification of flu-specific IgG levels in culture supernatants from the indicated treatment groups on days 4 and 7. Data are presented as mean ± s.e.m. The statistics were obtained by one-way ANOVA coupled with Dunnett’s multiple-comparisons test (e, f, and i-k) .
Invivomab Anti Human Cd3, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/invivomab anti human cd3/product/Bio X Cell
Average 94 stars, based on 1 article reviews
invivomab anti human cd3 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
anti human cd3  (Elabscience Biotechnology)
94
Elabscience Biotechnology anti human cd3
a. Dose–response curves showing pSMAD2/3 levels in human CD4- or CD8α-transduced HEK293 cells measured using a pSMAD–induced SEAP assay. b. Dose-dependent curves showing numbers of in vitro –cultured CD4 or CD8 T cells treated with the indicated proteins on day 5. c. Schematic of the experimental design for human spleen organoid culture, LAIV stimulation, and protein treatments. d. Representative flow cytometry plots showing percentages of CD38 Ki-67 cells in CD4 or CD8 T cells from the indicated treatment groups. e. Quantification of CD38 Ki-67 cell percentages in CD4 or CD8 T cells from the indicated treatment groups. f. Quantification of CD38 Ki-67 CD4 or CD8 T cell percentages among total <t>CD3</t> <t>T</t> cells from the indicated treatment groups. g. Dose–response curves showing pSMAD2/3 levels in human CD19-transduced HEK293 cells measured using a pSMAD-induced SEAP assay. h. Representative flow cytometry plots showing CD38 high PB percentages in B cells from the indicated treatment groups. i. Quantification of CD38 high PB percentages among total leukocytes from the indicated treatment groups. j. Quantification of CD38 expression levels in CD38 low non-PB from the indicated treatment groups. k. Quantification of flu-specific IgG levels in culture supernatants from the indicated treatment groups on days 4 and 7. Data are presented as mean ± s.e.m. The statistics were obtained by one-way ANOVA coupled with Dunnett’s multiple-comparisons test (e, f, and i-k) .
Anti Human Cd3, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human cd3/product/Elabscience Biotechnology
Average 94 stars, based on 1 article reviews
anti human cd3 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
anti cd3  (Elabscience Biotechnology)
93
Elabscience Biotechnology anti cd3
a. Dose–response curves showing pSMAD2/3 levels in human CD4- or CD8α-transduced HEK293 cells measured using a pSMAD–induced SEAP assay. b. Dose-dependent curves showing numbers of in vitro –cultured CD4 or CD8 T cells treated with the indicated proteins on day 5. c. Schematic of the experimental design for human spleen organoid culture, LAIV stimulation, and protein treatments. d. Representative flow cytometry plots showing percentages of CD38 Ki-67 cells in CD4 or CD8 T cells from the indicated treatment groups. e. Quantification of CD38 Ki-67 cell percentages in CD4 or CD8 T cells from the indicated treatment groups. f. Quantification of CD38 Ki-67 CD4 or CD8 T cell percentages among total <t>CD3</t> <t>T</t> cells from the indicated treatment groups. g. Dose–response curves showing pSMAD2/3 levels in human CD19-transduced HEK293 cells measured using a pSMAD-induced SEAP assay. h. Representative flow cytometry plots showing CD38 high PB percentages in B cells from the indicated treatment groups. i. Quantification of CD38 high PB percentages among total leukocytes from the indicated treatment groups. j. Quantification of CD38 expression levels in CD38 low non-PB from the indicated treatment groups. k. Quantification of flu-specific IgG levels in culture supernatants from the indicated treatment groups on days 4 and 7. Data are presented as mean ± s.e.m. The statistics were obtained by one-way ANOVA coupled with Dunnett’s multiple-comparisons test (e, f, and i-k) .
Anti Cd3, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd3/product/Elabscience Biotechnology
Average 93 stars, based on 1 article reviews
anti cd3 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
anti human cd3 apc cd4fitc cd8a pe cocktail  (Elabscience Biotechnology)
93
Elabscience Biotechnology anti human cd3 apc cd4fitc cd8a pe cocktail
a. Dose–response curves showing pSMAD2/3 levels in human CD4- or CD8α-transduced HEK293 cells measured using a pSMAD–induced SEAP assay. b. Dose-dependent curves showing numbers of in vitro –cultured CD4 or CD8 T cells treated with the indicated proteins on day 5. c. Schematic of the experimental design for human spleen organoid culture, LAIV stimulation, and protein treatments. d. Representative flow cytometry plots showing percentages of CD38 Ki-67 cells in CD4 or CD8 T cells from the indicated treatment groups. e. Quantification of CD38 Ki-67 cell percentages in CD4 or CD8 T cells from the indicated treatment groups. f. Quantification of CD38 Ki-67 CD4 or CD8 T cell percentages among total <t>CD3</t> <t>T</t> cells from the indicated treatment groups. g. Dose–response curves showing pSMAD2/3 levels in human CD19-transduced HEK293 cells measured using a pSMAD-induced SEAP assay. h. Representative flow cytometry plots showing CD38 high PB percentages in B cells from the indicated treatment groups. i. Quantification of CD38 high PB percentages among total leukocytes from the indicated treatment groups. j. Quantification of CD38 expression levels in CD38 low non-PB from the indicated treatment groups. k. Quantification of flu-specific IgG levels in culture supernatants from the indicated treatment groups on days 4 and 7. Data are presented as mean ± s.e.m. The statistics were obtained by one-way ANOVA coupled with Dunnett’s multiple-comparisons test (e, f, and i-k) .
Anti Human Cd3 Apc Cd4fitc Cd8a Pe Cocktail, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human cd3 apc cd4fitc cd8a pe cocktail/product/Elabscience Biotechnology
Average 93 stars, based on 1 article reviews
anti human cd3 apc cd4fitc cd8a pe cocktail - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
cd4 percp cy 5 5  (Bio-Rad)
93
Bio-Rad cd4 percp cy 5 5
a. Dose–response curves showing pSMAD2/3 levels in human CD4- or CD8α-transduced HEK293 cells measured using a pSMAD–induced SEAP assay. b. Dose-dependent curves showing numbers of in vitro –cultured CD4 or CD8 T cells treated with the indicated proteins on day 5. c. Schematic of the experimental design for human spleen organoid culture, LAIV stimulation, and protein treatments. d. Representative flow cytometry plots showing percentages of CD38 Ki-67 cells in CD4 or CD8 T cells from the indicated treatment groups. e. Quantification of CD38 Ki-67 cell percentages in CD4 or CD8 T cells from the indicated treatment groups. f. Quantification of CD38 Ki-67 CD4 or CD8 T cell percentages among total <t>CD3</t> <t>T</t> cells from the indicated treatment groups. g. Dose–response curves showing pSMAD2/3 levels in human CD19-transduced HEK293 cells measured using a pSMAD-induced SEAP assay. h. Representative flow cytometry plots showing CD38 high PB percentages in B cells from the indicated treatment groups. i. Quantification of CD38 high PB percentages among total leukocytes from the indicated treatment groups. j. Quantification of CD38 expression levels in CD38 low non-PB from the indicated treatment groups. k. Quantification of flu-specific IgG levels in culture supernatants from the indicated treatment groups on days 4 and 7. Data are presented as mean ± s.e.m. The statistics were obtained by one-way ANOVA coupled with Dunnett’s multiple-comparisons test (e, f, and i-k) .
Cd4 Percp Cy 5 5, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd4 percp cy 5 5/product/Bio-Rad
Average 93 stars, based on 1 article reviews
cd4 percp cy 5 5 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
ucht1  (fluidigm)
94
fluidigm ucht1
a. Dose–response curves showing pSMAD2/3 levels in human CD4- or CD8α-transduced HEK293 cells measured using a pSMAD–induced SEAP assay. b. Dose-dependent curves showing numbers of in vitro –cultured CD4 or CD8 T cells treated with the indicated proteins on day 5. c. Schematic of the experimental design for human spleen organoid culture, LAIV stimulation, and protein treatments. d. Representative flow cytometry plots showing percentages of CD38 Ki-67 cells in CD4 or CD8 T cells from the indicated treatment groups. e. Quantification of CD38 Ki-67 cell percentages in CD4 or CD8 T cells from the indicated treatment groups. f. Quantification of CD38 Ki-67 CD4 or CD8 T cell percentages among total <t>CD3</t> <t>T</t> cells from the indicated treatment groups. g. Dose–response curves showing pSMAD2/3 levels in human CD19-transduced HEK293 cells measured using a pSMAD-induced SEAP assay. h. Representative flow cytometry plots showing CD38 high PB percentages in B cells from the indicated treatment groups. i. Quantification of CD38 high PB percentages among total leukocytes from the indicated treatment groups. j. Quantification of CD38 expression levels in CD38 low non-PB from the indicated treatment groups. k. Quantification of flu-specific IgG levels in culture supernatants from the indicated treatment groups on days 4 and 7. Data are presented as mean ± s.e.m. The statistics were obtained by one-way ANOVA coupled with Dunnett’s multiple-comparisons test (e, f, and i-k) .
Ucht1, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ucht1/product/fluidigm
Average 94 stars, based on 1 article reviews
ucht1 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

Image Search Results


The information of antibodies used for western blot, immunohistochemistry, and flow cytometry

Journal: Journal of Translational Medicine

Article Title: Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer

doi: 10.1186/s12967-021-03073-0

Figure Lengend Snippet: The information of antibodies used for western blot, immunohistochemistry, and flow cytometry

Article Snippet: CD3 and isotype , Human , 5 μl of antibody per test , Elabscience, E-AB-F1001E , Flow cytometry.

Techniques: Western Blot, Immunohistochemistry, Flow Cytometry

a. Dose–response curves showing pSMAD2/3 levels in human CD4- or CD8α-transduced HEK293 cells measured using a pSMAD–induced SEAP assay. b. Dose-dependent curves showing numbers of in vitro –cultured CD4 or CD8 T cells treated with the indicated proteins on day 5. c. Schematic of the experimental design for human spleen organoid culture, LAIV stimulation, and protein treatments. d. Representative flow cytometry plots showing percentages of CD38 Ki-67 cells in CD4 or CD8 T cells from the indicated treatment groups. e. Quantification of CD38 Ki-67 cell percentages in CD4 or CD8 T cells from the indicated treatment groups. f. Quantification of CD38 Ki-67 CD4 or CD8 T cell percentages among total CD3 T cells from the indicated treatment groups. g. Dose–response curves showing pSMAD2/3 levels in human CD19-transduced HEK293 cells measured using a pSMAD-induced SEAP assay. h. Representative flow cytometry plots showing CD38 high PB percentages in B cells from the indicated treatment groups. i. Quantification of CD38 high PB percentages among total leukocytes from the indicated treatment groups. j. Quantification of CD38 expression levels in CD38 low non-PB from the indicated treatment groups. k. Quantification of flu-specific IgG levels in culture supernatants from the indicated treatment groups on days 4 and 7. Data are presented as mean ± s.e.m. The statistics were obtained by one-way ANOVA coupled with Dunnett’s multiple-comparisons test (e, f, and i-k) .

Journal: bioRxiv

Article Title: Selective Immune Silencing by Targeted TGF-β Agonists

doi: 10.64898/2026.01.19.700410

Figure Lengend Snippet: a. Dose–response curves showing pSMAD2/3 levels in human CD4- or CD8α-transduced HEK293 cells measured using a pSMAD–induced SEAP assay. b. Dose-dependent curves showing numbers of in vitro –cultured CD4 or CD8 T cells treated with the indicated proteins on day 5. c. Schematic of the experimental design for human spleen organoid culture, LAIV stimulation, and protein treatments. d. Representative flow cytometry plots showing percentages of CD38 Ki-67 cells in CD4 or CD8 T cells from the indicated treatment groups. e. Quantification of CD38 Ki-67 cell percentages in CD4 or CD8 T cells from the indicated treatment groups. f. Quantification of CD38 Ki-67 CD4 or CD8 T cell percentages among total CD3 T cells from the indicated treatment groups. g. Dose–response curves showing pSMAD2/3 levels in human CD19-transduced HEK293 cells measured using a pSMAD-induced SEAP assay. h. Representative flow cytometry plots showing CD38 high PB percentages in B cells from the indicated treatment groups. i. Quantification of CD38 high PB percentages among total leukocytes from the indicated treatment groups. j. Quantification of CD38 expression levels in CD38 low non-PB from the indicated treatment groups. k. Quantification of flu-specific IgG levels in culture supernatants from the indicated treatment groups on days 4 and 7. Data are presented as mean ± s.e.m. The statistics were obtained by one-way ANOVA coupled with Dunnett’s multiple-comparisons test (e, f, and i-k) .

Article Snippet: For human in vitro cultures, T cells were plated at 0.75 × 10 6 cells/mL in flat-bottom 12-well plates coated overnight with 5 μg/mL InVivoMAb anti-human CD3 (BE0001, Bio X Cell) and 2.5 μg/mL InVivoMAb anti-human CD28 (BE0248, Bio X Cell) in the presence of 10 ng/mL recombinant human IL-2 (202-IL, R&D Systems) for 3 days.

Techniques: SEAP Assay, In Vitro, Cell Culture, Flow Cytometry, Expressing